The group is involved in several projects.

  • The impact of modern treatment on the clinical course of Familial hypercholesterolemia (FH). Morbidity, mortality and use of medication in FH studied by using data from central health registers. The aim of the project is to provide the best possible description of key health and to discuss this knowledge in relation to the major health challenges that are associated with FH. Such knowledge may contribute to better health among FH patients.
  • Functional food, food supplements, omega-3 fatty acids and effects on cardiovascular risk factors.
  • Low carbohydrate diet in relation to risk factors for atherosclerosis. The issue will be examined by studying the biochemical; genetic, epigenetic, physiological, clinical and psychological effects of a low carbohydrate diet for a short time (three weeks) and long (one year) both in persons with normal body mass index (BMI) and in persons with BMI above average.
  • Cardiovascular risk among taxi drivers in Oslo in relation to dietary habits, life style and familial cardiovascular history.
  • Inflammation and the effects of dietary modulation in subjects at risk for cardiovascular disease and healthy subjects.
  • Adverse effects of statins. Mechanisms and physiology in patients with muscular side effects
  • Treatment of patients with homozygous familial hypercholesterolemia including LDL- Apheresis. Follow up of all Norwegian patients with Homozygous Familial Hypercholesterolemia
  • Long-term Follow-up of children with familial hypercholesterolemia after participation in drug trials. A qualitative study to examine the first children who started treatment early cholesterol in Norway (long-term follow-up (> 10 years).
  • The relationship between diet, lipids and other disease markers in children with familial hypercholesterolemia.
Published Dec. 1, 2011 9:50 AM - Last modified Dec. 1, 2011 9:51 AM